Center-Authored Papers

Filters: Author is Hirsch, Bradford R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Hirsch BR, Lyman GH.  2011.  Biosimilars: are they ready for primetime in the United States? Journal of the National Comprehensive Cancer Network : JNCCN. 9(8):934-42;quiz943. Abstract
Hirsch BR, Lyman GH.  2011.  Breast cancer screening with mammography.. Current oncology reports. 13(1):63-70. Abstract
I
Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH.  2015.  Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.. JAMA oncology. 1(2):158-66. Abstract
M
Dinan MA, Hirsch BR, Lyman GH.  2015.  Management of chemotherapy-induced neutropenia: measuring quality, cost, and value.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(1):e1-7. Abstract
P
Hirsch BR, Lyman GH.  2012.  Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.. PharmacoEconomics. 30(6):497-511. Abstract
W
Hirsch BR, Lyman GH.  2013.  Will biosimilars gain momentum? Journal of the National Comprehensive Cancer Network : JNCCN. 11(10):1291-7. Abstract